NOVONEX Trademark

Trademark Overview

On Monday, April 17, 2000, a trademark application was filed for NOVONEX with the United States Patent and Trademark Office. The USPTO has given the NOVONEX trademark a serial number of 76029874. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, November 14, 2004. This trademark is owned by Onconova Therapeutics Inc.. The NOVONEX trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic drugs for cancer and proliferative diseases
novonex

General Information

Serial Number76029874
Word MarkNOVONEX
Filing DateMonday, April 17, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, November 14, 2004
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 21, 2001

Trademark Statements

Description of MarkThe second "O" in design form is in the color red and color is claimed as a feature of the mark.
Goods and ServicesTherapeutic drugs for cancer and proliferative diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 8, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOnconova Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648
Party NameOnconova Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Trademark Events

Event DateEvent Description
Friday, March 4, 2005ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, March 4, 2005ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 26, 2004CASE FILE IN TICRS
Wednesday, June 2, 2004ASSIGNED TO EXAMINER
Monday, May 10, 2004EXTENSION 5 GRANTED
Tuesday, April 13, 2004EXTENSION 5 FILED
Thursday, January 1, 2004EXTENSION 4 GRANTED
Thursday, November 13, 2003EXTENSION 4 FILED
Wednesday, May 5, 2004PETITION TO REVIVE-GRANTED
Wednesday, April 28, 2004PAPER RECEIVED
Tuesday, April 13, 2004PAPER RECEIVED
Friday, January 30, 2004PETITION TO REVIVE-RECEIVED
Friday, January 30, 2004PAPER RECEIVED
Monday, January 12, 2004ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 1, 2003EXTENSION 3 GRANTED
Tuesday, May 13, 2003EXTENSION 3 FILED
Saturday, March 1, 2003EXTENSION 2 GRANTED
Wednesday, November 13, 2002EXTENSION 2 FILED
Thursday, August 1, 2002EXTENSION 1 GRANTED
Monday, May 13, 2002EXTENSION 1 FILED
Tuesday, September 9, 2003PETITION TO REVIVE-GRANTED
Thursday, July 31, 2003COMMUNICATION RECEIVED FROM PETITIONER
Thursday, July 31, 2003PAPER RECEIVED
Tuesday, July 8, 2003INCOMPLETE PETITION NOTICE MAILED
Tuesday, June 17, 2003COMMUNICATION RECEIVED FROM PETITIONER
Tuesday, June 17, 2003PAPER RECEIVED
Wednesday, May 7, 2003INCOMPLETE PETITION NOTICE MAILED
Monday, November 18, 2002PETITION TO REVIVE-RECEIVED
Monday, November 18, 2002PAPER RECEIVED
Saturday, October 5, 2002ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 13, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2001PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2001NOTICE OF PUBLICATION
Tuesday, October 24, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 6, 2000EXAMINER'S AMENDMENT MAILED
Monday, September 25, 2000EXAMINER'S AMENDMENT MAILED
Tuesday, September 19, 2000ASSIGNED TO EXAMINER

Related Keywords

novonex diseases proliferative cancer drugs therapeutic